{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:57:40Z","timestamp":1790971060865,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1176\/appi.psy.45.5.371","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T13:33:17Z","timestamp":1094045597000},"page":"371-377","source":"Crossref","is-referenced-by-count":125,"title":["Tricyclic Antidepressants, QT Interval Prolongation, and Torsade de Pointes"],"prefix":"10.1016","volume":"45","author":[{"given":"W. Victor R.","family":"Vieweg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1176\/appi.psy.45.5.371_bib0005","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/01.CIR.84.5.1977","article-title":"Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias: a meta-analysis","volume":"84","author":"Morganroth","year":"1991","journal-title":"Circulation"},{"key":"10.1176\/appi.psy.45.5.371_bib0010","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.84.4.1831","article-title":"The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1176\/appi.psy.45.5.371_bib0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9149(88)90754-0","article-title":"Effects of encainide, flecainide, imipramine, and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS","volume":"61","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0020","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/jama.1993.03510200057032","article-title":"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST)","volume":"270","author":"Epstein","year":"1993","journal-title":"JAMA"},{"key":"10.1176\/appi.psy.45.5.371_bib0025","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.1993.03500200087039","article-title":"The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered","volume":"269","author":"Glassman","year":"1993","journal-title":"JAMA"},{"issue":"suppl K","key":"10.1176\/appi.psy.45.5.371_bib0030","doi-asserted-by":"crossref","first-page":"K70","DOI":"10.1016\/S1520-765X(01)90009-4","article-title":"Spectrum of drugs prolonging QT interval and the incidence of torsade de pointes","volume":"3","author":"Darpo","year":"2001","journal-title":"Eur Heart J Suppl"},{"key":"10.1176\/appi.psy.45.5.371_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002280100290","article-title":"Organizing evidence on QT prolongation and occurrence of torsade de pointes with non-antiarrhythmic drugs: a call for consensus","volume":"57","author":"De Ponti","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1176\/appi.psy.45.5.371_bib0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.1978.03280300045019","article-title":"Cardiovascular effects of tricyclic and tetracyclic antidepressants","volume":"239","author":"Burckhardt","year":"1978","journal-title":"JAMA"},{"key":"10.1176\/appi.psy.45.5.371_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-197713050-00001","article-title":"Maprotiline: a review of its pharmacologic properties and therapeutic efficacy in mental depressive states","volume":"13","author":"Pinder","year":"1977","journal-title":"Drugs"},{"key":"10.1176\/appi.psy.45.5.371_bib0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1185\/03007998009109483","article-title":"Comparison of the efficacy of sustained-release amitriptyline with maprotiline in the treatment of depressive illness","volume":"6","author":"Sims","year":"1980","journal-title":"Curr Med Res Opin"},{"key":"10.1176\/appi.psy.45.5.371_bib0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0735-6757(00)90027-5","article-title":"Prolonged QT interval and torsade de pointes caused by the combination of fluconazole and amitriptyline","volume":"18","author":"Dorsey","year":"2000","journal-title":"Am J Emerg Med"},{"key":"10.1176\/appi.psy.45.5.371_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-0736(85)80055-8","article-title":"Amitriptyline-induced torsade de pointes: successful therapy with atrial pacing","volume":"18","author":"Davison","year":"1985","journal-title":"J Electrocardiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0065","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(99)09449-0","article-title":"A child with cardiac arrhythmia and convulsions","volume":"354","author":"Manikoth","year":"1999","journal-title":"Lancet"},{"key":"10.1176\/appi.psy.45.5.371_bib0070","first-page":"353","article-title":"helicoidal ventricular tachycardia caused by amitriptyline","volume":"55","author":"Jerjes Sanchez Diaz","year":"1985","journal-title":"Arch Inst Cardiol Mex"},{"key":"10.1176\/appi.psy.45.5.371_bib0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000173500","article-title":"Congenital prolongation of Q-T interval: a family study of three generations","volume":"69","author":"Flugelman","year":"1982","journal-title":"Cardiology"},{"key":"10.1176\/appi.psy.45.5.371_bib0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1540-8159.1982.tb06570.x","article-title":"Doxepin induced torsade de pointes","volume":"5","author":"Strasberg","year":"1982","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.7326\/0003-4819-135-5-200109040-00026","article-title":"Doxepin-induced torsade de pointes tachycardia","volume":"135","author":"Alter","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1176\/appi.psy.45.5.371_bib0090","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0002-9149(83)80155-6","article-title":"QT prolongation and torsade de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline","volume":"51","author":"Herrmann","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/106002808401800908","article-title":"Fatal maprotiline intoxication","volume":"18","author":"Curtis","year":"1984","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1176\/appi.psy.45.5.371_bib0100","first-page":"123","article-title":"Torsade de pointes in a patient under long-term maprotiline therapy: apropos of a case","volume":"45","author":"Rialan","year":"1996","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1176\/appi.psy.45.5.371_bib0105","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1055\/s-2001-18880","article-title":"QT prolongation and torsade de pointes tachycardia during therapy with maprotiline: differential diagnostic and therapeutic aspects","volume":"126","author":"Lentini","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1176\/appi.psy.45.5.371_bib0110","first-page":"1058","article-title":"Torsade de pointes caused by tricyclic antidepressive agents: description of a clinical case","volume":"16","author":"Casazza","year":"1986","journal-title":"G Ital Cardiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1345\/aph.17351","article-title":"Torsade de pointes resulting from the addition of droperidol to an existing cytochrone P450 drug interaction","volume":"32","author":"Michalets","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1176\/appi.psy.45.5.371_bib0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/hrt.38.2.117","article-title":"Torsade de pointes; an atypical ventricular tachycardia","volume":"38","author":"Krikler","year":"1976","journal-title":"Br Heart J"},{"key":"10.1176\/appi.psy.45.5.371_bib0125","first-page":"1","article-title":"The QT interval","volume":"43","author":"Bednar","year":"2001","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1176\/appi.psy.45.5.371_bib0130","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/00004583-199611000-00018","article-title":"Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents","volume":"35","author":"Wilens","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1176\/appi.psy.45.5.371_bib0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00005344-199810000-00003","article-title":"Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel","volume":"32","author":"Casis","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1176\/appi.psy.45.5.371_bib0140","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjp.0703222","article-title":"Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline","volume":"129","author":"Jo","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1176\/appi.psy.45.5.371_bib0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.RES.74.4.687","article-title":"Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes","volume":"74","author":"Valenzuela","year":"1994","journal-title":"Circ Res"},{"key":"10.1176\/appi.psy.45.5.371_bib0150","series-title":"Cardiovascular Risk Associated With Schizophrenia and Its Treatment","first-page":"82","article-title":"Actions of antipsychotic drugs on ventricular action potential and ion channels","author":"Clements-Jewery","year":"2003"},{"key":"10.1176\/appi.psy.45.5.371_bib0155","unstructured":"US Food and Drug Administration: Center for Drug Evaluation and Research Briefing Information for Psychopharmacologic Drugs Advisory Committee Meeting, July 2000. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/00\/backgrd\/3619b1a.pdf"},{"key":"10.1176\/appi.psy.45.5.371_bib0160","unstructured":"US Food and Drug Administration Advisory Committee: Zeldox capsules (ziprasidone): summary of efficacy and safety and overall benefit risk relationship. Bethesda, Md, US Food and Drug Administration, 2000"},{"key":"10.1176\/appi.psy.45.5.371_bib0165","series-title":"Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2000"},{"issue":"5","key":"10.1176\/appi.psy.45.5.371_bib0170","first-page":"10","article-title":"Strategies to prevent fatal arrhythmias with antipsychotics","volume":"1","author":"Vieweg","year":"2002","journal-title":"Current Psychiatry"},{"key":"10.1176\/appi.psy.45.5.371_bib0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1991.tb01421.x","article-title":"A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland","volume":"84","author":"Mehtonen","year":"1991","journal-title":"Acta Psychiatr Scand"},{"key":"10.1176\/appi.psy.45.5.371_bib0180","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTcinterval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1176\/appi.psy.45.5.371_bib0185","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0736-4679(95)02019-5","article-title":"Five-year multicenter retrospective review of cyclobenzaprine toxicity","volume":"13","author":"Spiller","year":"2001","journal-title":"J Emerg Med"},{"key":"10.1176\/appi.psy.45.5.371_bib0190","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(01)00625-8","article-title":"The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities","volume":"110","author":"Naccarelli","year":"2001","journal-title":"Am J Med"},{"key":"10.1176\/appi.psy.45.5.371_bib0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1540-8167.2001.00268.x","article-title":"The Brugada syndrome: ionic basis and arrhythmia mechanisms","volume":"12","author":"Antzelevitch","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0205","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.RES.0000046046.53721.90","article-title":"Brugada syndrome: a decade of progress","volume":"91","author":"Antzelevitch","year":"2002","journal-title":"Circ Res"},{"key":"10.1176\/appi.psy.45.5.371_bib0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0002-9149(96)00727-8","article-title":"Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose","volume":"79","author":"Bolognesi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0215","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJM200205163462020","article-title":"Overdose of cyclic antidepressants and the Brugada syndrome","volume":"346","author":"Goldgran-Toledano","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1176\/appi.psy.45.5.371_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1540-8167.2001.00061.x","article-title":"Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome","volume":"12","author":"Rouleau","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1176\/appi.psy.45.5.371_bib0225","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/clc.4950250809","article-title":"Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine","volume":"25","author":"Babaliaros","year":"2002","journal-title":"Clin Cardiology"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318204701504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318204701504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T01:27:53Z","timestamp":1549243673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318204701504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0033318204701504"],"URL":"https:\/\/doi.org\/10.1176\/appi.psy.45.5.371","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}